Abiopharma

Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges

(19% Negative) CELCUITY INC. (CELC) Announces Delay in patients Trials for multiple solid tumor indications Due to Regulatory Process, Safety Review, Efficacy Assessment

Cardio Diagnostics Report Identifies Growing Rural Cardiovascular Care Gap Amid Ongoing Workforce Shortages and Access Challenges

New Form 424B2 - MORGAN STANLEY <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001839882-26-041531 <b>Size:</b> 518 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024869 <b>Size:</b> 832 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024868 <b>Size:</b> 559 KB

Director KERSTEN GEERT R 🟢 acquired 100.0K shares of CEL SCI CORP (CVM) at $1.38 Transaction Date: Aug 25, 2026 | Filing ID: 000008

SciSparc SPRC Notification

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001839882-26-041529 <b>Size:</b> 201 KB

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0000950103-26-012896 <b>Size:</b> 138 KB

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024867 <b>Size:</b> 815 KB

VCI Global Announces Galatron AI Factory, a Modular AI Data Center Platform with Roadmap to 500MW of Compute Capacity

SciSparc Advances Agentic AI Strategy with Addition of Internationally Recognized AI Expert Prof. Carmel Domshlak to Scientific Advisory Board

Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001918704-26-024864 <b>Size:</b> 832 KB